Screener
Pacific Biosciences of California PACB Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Pacific Biosciences of California’s reported figures.
Based on trailing twelve months.
The source filing: Pacific Biosciences of California’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 5:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001299130-26-000122
FAQ
- What is Pacific Biosciences of California's asset turnover?
- Pacific Biosciences of California (PACB) reported asset turnover of 0.2× in Q2 2026.
- How has Pacific Biosciences of California's asset turnover changed year-over-year?
- Pacific Biosciences of California's asset turnover increased by 51.1% year-over-year, from 0.1× to 0.2×.
- What is the long-term trend for Pacific Biosciences of California's asset turnover?
- Over 5 years (2020 to 2025), Pacific Biosciences of California's asset turnover has grown at a -11.5% compound annual growth rate (CAGR), from 0.3× to 0.2×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Pacific Biosciences of California's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude